Polymyositis associated with infliximab treatment for rheumatoid arthritis

(2006). Polymyositis associated with infliximab treatment for rheumatoid arthritis. Modern Rheumatology: Vol. 16, No. 6, pp. 410-411.

[1]  H. Hashimoto,et al.  A multicenter, double-blind, randomized, placebo controlled trial of infliximab combined with low dose methotrexate in Japanese patients with rheumatoid arthritis. , 2006, The Journal of rheumatology.

[2]  J. Ballet,et al.  Evolution of antinuclear antibodies and clinical patterns in patients with active rheumatoid arthritis with longterm infliximab therapy. , 2006, The Journal of rheumatology.

[3]  T. Mitsui,et al.  Involvement of mitochondria in myasthenia gravis complicated with dermatomyositis and rheumatoid arthritis: a case report , 2005, Acta Neuropathologica.

[4]  J. Musial,et al.  Polymyositis associated with infliximab treatment for rheumatoid arthritis. , 2003, Rheumatology.

[5]  M. Netea,et al.  Successful Treatment of Dermatomyositis and Polymyositis with Anti-Tumor-Necrosis-Factor-Alpha: Preliminary Observations , 2003, European Neurology.

[6]  O. Meyer,et al.  Anti-TNF-α-induced systemic lupus syndrome , 2003, Clinical Rheumatology.

[7]  O. Meyer,et al.  Anti-TNF-alpha-induced systemic lupus syndrome. , 2003, Clinical rheumatology.

[8]  E. Roddy,et al.  Non-Hodgkin's lymphoma in a patient with refractory dermatomyositis which had been treated with infliximab. , 2002, Rheumatology.

[9]  E. Gromnica-ihle,et al.  Clinical and Serological Aspects of Patients with Anti-Jo-1 Antibodies – an Evolving Spectrum of Disease Manifestations , 2000, Clinical Rheumatology.

[10]  E. A. Jenkins,et al.  D-penicillamine and polymyositis: the significance of the anti-Jo-1 antibody. , 1993, British journal of rheumatology.